¡Atención! Este sitio usa cookies y tecnologías similares.

Si no cambia la configuración de su navegador, usted acepta su uso. Saber más

Acepto

Bibliografía patologías crónicas

La bibliografía de las patologías crónicas se encuentra en los nutrientes correspondientes.

Bibliografía glutatión

 

  • Allen, J. (2008). "Inhaled glutathione for the prevention of air pollution-related health effects: a brief review." Altern Ther Health Med 14(3): 42-44.
  • Arosio, E., S. De Marchi, et al. (2002). "Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial." Mayo Clin Proc 77(8): 754-759.
  • Atkuri, K. R., J. J. Mantovani, et al. (2007). "N-Acetylcysteine--a safe antidote for cysteine/glutathione deficiency." Curr Opin Pharmacol 7(4): 355-359.
  • Balendiran, G. K., R. Dabur, et al. (2004). "The role of glutathione in cancer." Cell Biochem Funct 22(6): 343-352.
  • Barlow-Walden, L. R., R. J. Reiter, et al. (1995). "Melatonin stimulates brain glutathione peroxidase activity." Neurochem Int 26(5): 497-502.
  • Barrios, V., A. Calderon, et al. (2002). "N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients." Blood Press 11(4): 235-239.
  • Biswas, S. K. and I. Rahman (2009). "Environmental toxicity, redox signaling and lung inflammation: the role of glutathione." Mol Aspects Med 30(1-2): 60-76.
  • Blanco, R. A., T. R. Ziegler, et al. (2007). "Diurnal variation in glutathione and cysteine redox states in human plasma." Am J Clin Nutr 86(4): 1016-1023.
  • Bounous, G., S. Baruchel, et al. (1993). "Whey proteins as a food supplement in HIV-seropositive individuals." Clin Invest Med 16(3): 204-209.
  • Bounous, G. and P. Gold (1991). "The biological activity of undenatured dietary whey proteins: role of glutathione." Clin Invest Med 14(4): 296-309.
  • Chen, Y., Y. Yang, et al. (2007). "Hepatocyte-specific Gclc deletion leads to rapid onset of steatosis with mitochondrial injury and liver failure." Hepatology 45(5): 1118-1128.
  • Chow, H. H., I. A. Hakim, et al. (2007). "Modulation of human glutathione s-transferases by polyphenon e intervention." Cancer Epidemiol Biomarkers Prev 16(8): 1662-1666.
  • De Benedetto, F., A. Aceto, et al. (2005). "Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD." Pulm Pharmacol Ther 18(1): 41-47.
  • Droge, W. and E. Holm (1997). "Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction." FASEB J 11(13): 1077-1089.
  • Edwards, A. T., A. D. Blann, et al. (1994). "Systemic responses in patients with intermittent claudication after treadmill exercise." Br J Surg 81(12): 1738-1741.
  • Escobar, J., J. Pereda, et al. (2009). "Cross-talk between oxidative stress and pro-inflammatory cytokines in acute pancreatitis: a key role for protein phosphatases." Curr Pharm Des 15(26): 3027-3042.
  • Foschino Barbaro, M. P., G. Serviddio, et al. (2005). "Oxygen therapy at low flow causes oxidative stress in chronic obstructive pulmonary disease: Prevention by N-acetyl cysteine." Free Radic Res 39(10): 1111-1118.
  • Grandjean, E. M., P. Berthet, et al. (2000). "Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials." Clin Ther 22(2): 209-221.
  • Grey, V., S. R. Mohammed, et al. (2003). "Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein." J Cyst Fibros 2(4): 195-198.
  • Gross, C. L., J. K. Innace, et al. (1993). "Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard." Cell Biol Toxicol 9(3): 259-267.
  • Han, Y. H. and W. H. Park (2009). "The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione." Oncol Rep 22(2): 385-391.
  • Hansel, B., A. Kontush, et al. (2006). "Alterations in lipoprotein defense against oxidative stress in metabolic syndrome." Curr Atheroscler Rep 8(6): 501-509.
  • Herzenberg, L. A., S. C. De Rosa, et al. (1997). "Glutathione deficiency is associated with impaired survival in HIV disease." Proc Natl Acad Sci U S A 94(5): 1967-1972.
  • Hoshino, T., M. Okamoto, et al. (2008). "Redox-regulated mechanisms in asthma." Antioxid Redox Signal 10(4): 769-783.
  • Kaneto, H., Y. Kajimoto, et al. (1999). "Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity." Diabetes 48(12): 2398-2406.
  • Kasielski, M. and D. Nowak (2001). "Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease." Respir Med 95(6): 448-456.
  • Lieber, C. S. (2002). "S-adenosyl-L-methionine: its role in the treatment of liver disorders." Am J Clin Nutr 76(5): 1183S-1187S.
  • Loguercio, C., G. Nardi, et al. (1994). "Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease." Alcohol Alcohol 29(5): 597-604.
  • London, S. J. (2007). "Gene-air pollution interactions in asthma." Proc Am Thorac Soc 4(3): 217-220.
  • Maczurek, A., K. Hager, et al. (2008). "Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease." Adv Drug Deliv Rev 60(13-14): 1463-1470.
  • Manna, P., M. Sinha, et al. (2008). "Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid." Arch Toxicol 82(3): 137-149.
  • Marazzi, G., S. Rosanio, et al. (2008). "The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure." Curr Pharm Des 14(25): 2592-2604.
  • Marchetti, A. and R. Rossiter (2009). "Managing acute acetaminophen poisoning with oral versus intravenous N-acetylcysteine: a provider-perspective cost analysis." J Med Econ 12(4): 384-391.
  • Martina, V., A. Masha, et al. (2008). "Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes." Diabetes Care 31(5): 940-944.
  • Mastruzzo, C., N. Crimi, et al. (2002). "Role of oxidative stress in pulmonary fibrosis." Monaldi Arch Chest Dis 57(3-4): 173-176.
  • Micke, P., K. M. Beeh, et al. (2002). "Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients." Eur J Nutr 41(1): 12-18.
  • Micke, P., K. M. Beeh, et al. (2001). "Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients." Eur J Clin Invest 31(2): 171-178.
  • Moreno, Y. F., V. C. Sgarbieri, et al. (2006). "Features of whey protein concentrate supplementation in children with rapidly progressive HIV infection." J Trop Pediatr 52(1): 34-38.
  • Nadeem, A., A. Masood, et al. (2008). "Oxidant--antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options." Ther Adv Respir Dis 2(4): 215-235.
  • Nencini, C., G. Giorgi, et al. (2007). "Protective effect of silymarin on oxidative stress in rat brain." Phytomedicine 14(2-3): 129-135.
  • Newman, K. P., M. T. Neal, et al. (2007). "The importance of lost minerals in heart failure." Cardiovasc Hematol Agents Med Chem 5(4): 295-299.
  • Nwose EU, Jelinek HF, Richards RS, Kerr PG. Erythrocyte oxidative stress in clinical management of diabetes and its cardiovascular complications. Br J Biomed Sci. 2007;64:35-43.
  • Ozaydin, M., O. Peker, et al. (2008). "N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study." Eur Heart J 29(5): 625-631.
  • Papi, A., F. Luppi, et al. (2006). "Pathophysiology of exacerbations of chronic obstructive pulmonary disease." Proc Am Thorac Soc 3(3): 245-251.
  • Paravicini, T. M. and R. M. Touyz (2006). "Redox signaling in hypertension." Cardiovasc Res 71(2): 247-258.
  • Parodi, O., R. De Maria, et al. (2007). "Redox state, oxidative stress and endothelial dysfunction in heart failure: the puzzle of nitrate-thiol interaction." J Cardiovasc Med (Hagerstown) 8(10): 765-774.
  • Pastore, A., F. Piemonte, et al. (2001). "Determination of blood total, reduced, and oxidized glutathione in pediatric subjects." Clin Chem 47(8): 1467-1469.
  • Pereira, C. F. and C. R. Oliveira (2000). "Oxidative glutamate toxicity involves mitochondrial dysfunction and perturbation of intracellular Ca2+ homeostasis." Neurosci Res 37(3): 227-236.
  • Perricone, C., C. De Carolis, et al. (2009). "Glutathione: a key player in autoimmunity." Autoimmun Rev 8(8): 697-701.
  • Pessah-Rasmussen, H., L. Stavenow, et al. (1990). "Lack of glutathione transferase activity in intermittent claudication." Int Angiol 9(2): 70-74.
  • Pompella, A., A. Visvikis, et al. (2003). "The changing faces of glutathione, a cellular protagonist." Biochem Pharmacol 66(8): 1499-1503.
  • Rahman, I. (2008). "Antioxidant therapeutic advances in COPD." Ther Adv Respir Dis 2(6): 351-374.
  • Rottner, M., J. M. Freyssinet, et al. (2009). "Mechanisms of the noxious inflammatory cycle in cystic fibrosis." Respir Res 10: 23.
  • Rush, J. W. and R. J. Ford (2007). "Nitric oxide, oxidative stress and vascular endothelium in health and hypertension." Clin Hemorheol Microcirc 37(1-2): 185-192.
  • Salinthone, S., V. Yadav, et al. (2008). "Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS." Endocr Metab Immune Disord Drug Targets 8(2): 132-142.
  • Sampsonas, F., M. A. Archontidou, et al. (2007). "Genetic alterations of glutathione S-transferases in asthma: do they modulate lung growth and response to environmental stimuli?" Allergy Asthma Proc 28(3): 282-286.
  • Saviuc, P. and V. Danel (2008). "[Acute acetaminophen overdose]." Rev Prat 58(8): 861-865.
  • Scanu, A. M. and C. Edelstein (2008). "HDL: bridging past and present with a look at the future." FASEB J 22(12): 4044-4054.
  • Sener, G., A. Sakarcan, et al. (2007). "Role of garlic in the prevention of ischemia-reperfusion injury." Mol Nutr Food Res 51(11): 1345-1352.
  • Shangari, N., W. R. Bruce, et al. (2003). "Toxicity of glyoxals--role of oxidative stress, metabolic detoxification and thiamine deficiency." Biochem Soc Trans 31(Pt 6): 1390-1393.
  • Shay, K. P., R. F. Moreau, et al. (2009). "Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential." Biochim Biophys Acta 1790(10): 1149-1160.
  • Singh, U. and I. Jialal (2008). "Alpha-lipoic acid supplementation and diabetes." Nutr Rev 66(11): 646-657.
  • Sisillo, E., R. Ceriani, et al. (2008). "N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial." Crit Care Med 36(1): 81-86.
  • Stey, C., J. Steurer, et al. (2000). "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." Eur Respir J 16(2): 253-262.
  • Thornalley, P. J. (2007). "Endogenous alpha-oxoaldehydes and formation of protein and nucleotide advanced glycation endproducts in tissue damage." Novartis Found Symp 285: 229-243; discussion 243-226.
  • Tsutsui, H., S. Kinugawa, et al. (2009). "Mitochondrial oxidative stress and dysfunction in myocardial remodelling." Cardiovasc Res 81(3): 449-456.
  • Valenzuela, A., M. Aspillaga, et al. (1989). "Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat." Planta Med 55(5): 420-422.
  • Vendemiale, G., E. Altomare, et al. (1989). "Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease." Scand J Gastroenterol 24(4): 407-415.
  • Vincent, H. K., K. E. Innes, et al. (2007). "Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity." Diabetes Obes Metab 9(6): 813-839.
  • Witschi, A., S. Reddy, et al. (1992). "The systemic availability of oral glutathione." Eur J Clin Pharmacol 43(6): 667-669.
  • www.immunocal.com. (2009). "PDR® entry for Immunocal Powder Sachets (Immunotec)." Retrieved 17-Dec, 2009, from http://www.drugs.com/pdr/immunocal-powder-sachets.html.
  • Yung, L. M., F. P. Leung, et al. (2006). "Reactive oxygen species in vascular wall." Cardiovasc Hematol Disord Drug Targets 6(1): 1-19.

Bibliografía carnitina

 

  • Amin KA, Nagy MA. Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats. Diabetol Metab Syndr. 2009;1(1):17.
  • Andreozzi GM. Propionyl l-carnitine: intermittent claudication and peripheral arterial disease. Expert Opin Pharmacother. 2009;10(16):2697-707.
  • Arduini A, Bonomini M, Savica V, Amato A, Zammit V. Carnitine in metabolic disease: potential for pharmacological intervention. Pharmacol Ther. 2008;120(2):149-56.
  • Asilsoy S, Bekem O, Karaman O, Uzuner N, Kavukçu S. Serum total and free carnitine levels in children with asthma. World J Pediatr. 2009;5(1):60-2.
  • Bloomer RJ, Smith WA. Oxidative stress in response to aerobic and anaerobic power testing: Influence of exercise training and carnitine supplementation. Res Sports Med 2009;17:1-16.
  • Borghi-Silva A, Baldissera V, Sampaio LM, Pires-DiLorenzo VA, Jamami M, Demonte A, Marchini JS, Costa D. L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res. 2006;39(4):465-74.
  • Brevetti G, Chiariello M, Ferulano G, Policicchio A, Nevola E, Rossini A, Attisano T, Ambrosio G, Siliprandi N, Angelini C.Increases in walking distance in patients with peripheral vascular disease treated with L-carnitine: a double-blind, cross-over study. Circulation. 1988;77(4):767-73.
  • Brevetti G, Diehm C, Lambert D.European multicenter study on propionyl-L-carnitine in intermittent claudication. J Am Coll Cardiol. 1999;34(5):1618-24.
  • Cha YS. Effects of L-carnitine on obesity, diabetes, and as an ergogenic aid. Asia Pac J Clin Nutr. 2008;17 Suppl 1:306-8.
  • Costell M, O’Connor J, Grisolia S. Age-dependent decrease of carnitine content in muscle of mice and humans. Biochem Biophys Res Commun 1989;161:1135- 43.
  • Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Shaiova L, Fleishman S, Lapin J, Klein E, Lesage P, Portenoy R, Esteban-Cruciani N. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann N Y Acad Sci. 2004;1033:168-76.
  • Cruciani RA, Dvorkin E, Homel P, Culliney B, Malamud S, Lapin J, Portenoy RK, Esteban-Cruciani N. L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study. Pain Symptom Manage. 2009;37(4):622-31.
  • Davis PA, Mormino P, Savica V, Calò LA. L-carnitine, inflammation and hypertension. Nephrology 2009;14:264-265.
  • De Grandis D.Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review. CNS Drugs. 2007;21 Suppl 1:39-43; discussion 45-6.
  • Eder K, Felgner J, Becker K, Kluge H. Free and total carnitine concentrations in pig plasma after oral ingestion of various L-carnitine compounds. Int J Vitam Nutr Res. 2005;75(1):3-9.
  • Erguven M, Yilmaz O, Koc S, Caki S, Ayhan Y, Donmez M, Dolunay G. A case of early diagnosed carnitine deficiency presenting with respiratory symptoms. Ann Nutr Metab. 2007;51(4):331-4.
  • Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C: Therapeutic effects of L-carnitine propionyl-L-carnitine on cardiovascular diseases: a review. Ann NY Acad Sci 2004, 1033:79-91.
  • Hathcock JN, Shao A. Risk assessment for carnitine. Reg Tox Pharmacology 2006;46:23-28.
  • Hoppel C.The role of carnitine in normal and altered fatty acid metabolism. Am J Kidney Dis. 2003;41(4 Suppl 4):S4-12.
  • Irat AM, Aktan F, Ozansoy G. Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. J Pharm Pharmacol 2003;55:1389-95.
  • Kendler BS.  Supplemental conditionally essential nutrients in cardiovascular disease therapy. J. Cardiovasc Nurs. 2006 Jan-Feb;21(1):9-16.
  • Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M: L-carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes. Am J Clin Nutr 2009, 89(1):71-76.
  • Marriage B, Clandinin MT, Glerum DM. Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc. 2003;103(8):1029-38.
  • Noland RC, Koves TR, Seiler SE, Lum H, Lust RM, Ilkayeva O, Stevens RD, Hegardt FG, Muoio DM. Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control. J Biol Chem. 2009 Aug 21;284(34):22840-52.
  • aRajasekar P, Anuradha CV. L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management. Acta Diabetol. 2007;44(2):83-90.
  • bRajasekar P, Anuradha CV: Effect of L-carnitine on skeletal muscle lipids oxidative stress in rats fed high-fructose diet. Exp Diabetes Res. 2007, 2007:72741.
  • Rizos I. Three-year survival of patients with heart failure caused by dilated cardiomyopathy and L-carnitine administration. Am Heart J 2000;139:S120 -3.
  • Sinatra ST. Metabolic cardiology: an integrative strategy in the treatment of congestive heart failure. Altern Ther Health Med 2009;15(3):44-52.
  • Soukoulis V, Dihu JB, Sole M, Anker SD, Cleland J, Fonarow GC, Metra M, Pasini E, Strzelczyk T, Taegtmeyer H, Gheorghiade M. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol. 2009 27;54(18):1660-73.
  • Uzuner N, Kavukcu S, Yilmaz O, Ozkal S, Islekel H, Karaman O, et al. The role of L-carnitine in treatment of a murine model of asthma. Acta Med Okayama 2002;56:295-301.
  • Plioplys AV, Plioplys S. Serum levels of carnitine in chronic fatigue syndrome: clinical correlates. Neuropsychobiology. 1995; 32 (3):132-8.
  • Porter NS, Jason LA, Boulton A, Bothne N, Coleman B.Alternative medical interventions used in the treatment and management of myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia. J Altern Complement Med. 2010 Mar;16(3):235-49.
  • Reuter SE, Evans AMLong-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J Intern Med. 2011 Jul; 270 (1):76-84. doi: 10.1111/j. 1365-2796. 2010. 02341. Epub 2011 Jan 19).
  • Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. 2000 Apr;5(2):93-108.

Bibliografía N-acetilcisteína

 

  • Atkuri KR, mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcisteine - a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007;7:355-359.
  • Baker DH. Comparative Species Utilization and Toxicity of Sulfur Amino Acids. J Nutr 2006;1670-1675.
  • Barrios V, Calderón A, Navarro-Cid J, Lahera V, Ruilope LM. N-Acetylcysteine Potentiates the Antihypertensive Effect of ACE Inhibitors in Hypertensive Patients. Blood Press 2002;11:235-239.
  • Billinger M, Hess OM, Meier B. Prevention of contrast-induced renal dysfunction by N-acetylcysteine. Truth or myth? Eur Heart J 2004;25:188-189.
  • Biswas, S. K. and I. Rahman (2009). "Environmental toxicity, redox signaling and lung inflammation: the role of glutathione." Mol Aspects Med 30(1-2): 60-76.
  • Blanco RA, Ziegler TR, Carlson BA, Cheng PY, Park Y, Cotsonis GA, Accardi CJ, Jones DP. Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nut 2007;86:1016-1023.
  • Blouet C, Mariotti F, Azzout-Marniche D, Mathé V, Mikogami T, Tomé D, Huneau JF. Dietary cysteine alleviates sucrose-induced oxidative stress and insulin resistance. Free Rad Biol Med 2007;42;1089-1097.
  • Bouman CCS, Schultz MJ. N-acetylcysteine: Multiple organ saver during cardiac surgery? Crit Care Med 2008;36(1):338-340.
  • Briguori C, Colombo A, Violante A, Balestrieri P, Manganelli F, Elia PP, Golia B, Lepore S, Riviezzo G, Scarpato P, Focaccio A, Librera M, Bonizzoni E, Ricciardelli B. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004;25:206-211.
  • Brosnan JT, Brosnan ME. The Sulfur-Containing Amino Acids: An Overview. J Nutr 2006:1636-1640.
  • Courtney-Martin G, Rafii M, Wykes LJ, Ball RO, Pencharz PB. Methionine-Adequate Cysteine-Free Diet Does Not Limit Erythrocyte Glutathione Synthesis in Young Healthy Adult Men. J Nutr 2008;138:2172-2178.
  • Dilger RN, Baker DH. Excess Dietary L-Cysteine Causes Lethal Metabolic Acidosis in Chicks. J Nutr 2008;138(9):1628-1633.
  • Grimble RF. The Effects of Sulfur Amino Acid Intake on Immune Function in Humans. J Nutr 2006;136:1660-1665.
  • Guijarro LG, Mate J, Gisbert JP, Perez-Calle JL, Marin-Jimenez I, Arriaza E, Olleros T, Delgado M, Castillejo MS, Prieto-Merino D, Gonzalez Lara V, Salvador Peña A. N-acetyl-L-cysteine combined with mesalamine in the treatment of ulcerative colitis: Randomized, placebo-controlled pilot study. World J Gastroenterol 2008;14(18):2851-2857.
  • Kaneko Y, Kimura Y, Kimura H, Niki L. (2006). L-cysteine inhibits insulin release from the pancreatic beta-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes 2006 May;55(5):1391-7.
  • Krug S, Zhang Y, Mori TA, Croft KD, Vickers JJ, Langton LK, Whitworth JA. N-Acetylcysteine prevents but does not reverse dexamethasone-induced hypertension. Clin Exp Pharm Physiol 2008;35:979-981.
  • Li P, Yin YL, Li D, Kim SW, Wu G. Amino acids and immune function. Brit J Nutr 2007;98:237-252.
  • Martina V, Masha A, Gigliardi VR, Brocato L, Manzano E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, Iannone A. Long-Term N-Acetylcysteine and L-Arginine Administration Reduces Endothelial Activation and Systolic Blood Pressure in Hypertensive Patients With Type 2 Diabetes. Diab Care 2008;31:940-944.
  • Meister, A. (1994). "Glutathione-ascorbic acid antioxidant system in animals." J Biol Chem 269(13): 9397-9400.
  • Nimni ME, Han B, Cordoba F. Are we getting enough sulfur in our diet? Nutr Metab 2007;4:24-36.
  • Nualart, F. J., C. I. Rivas, et al. (2003). "Recycling of vitamin C by a bystander effect." J Biol Chem 278(12): 10128-10133.
  • Oda H. Functions of Sulfur-Containing Amino Acids in Lipid Metabolism. J Nutr 2006;136:1666-1669.
  • Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E, Ozguner F, Dogan A, Ibrisim E. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008;29:625-631..
  • Paul J. Millea 2009. American Academy of Family Physicians; N-Acetylcysteine: Multiple Clinical Applications; Paul J. Millea; August 2009
  • Perricone, C., C. De Carolis, et al. (2009). "Glutathione: a key player in autoimmunity." Autoimmun Rev 8(8): 697-701.
  • Pizzuli L, Hagendorff A, Zirbes M, Jung W, Lüderitz B. N-Acetylcysteine Attenuates Nitroglycerin Tolerance in Patients With Angina Pectoris and Normal Left Ventricular Function. Am J Cardiol 1997;79:28-33
  • Riedijk MA, Voortman G, van Beek RTH, Baartmans MGA, Wafelman LS, van Goudoever JB. Cyst(e)ine Requirements in Enterally Fed Very Low Birth Weight Preterm Infants. Pediatrics 2008;121(3):561-567.
  • Rizvi SI, Maurya PK. L-Cysteine Influx in Erythrocytes as a Function of Human Age. Rejuv Res 2008;11(3):661-665.
  • Rottner, M., J. M. Freyssinet, et al. (2009). "Mechanisms of the noxious inflammatory cycle in cystic fibrosis." Respir Res 10: 23.
  • Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial. Crit Care Med 2008;36(1):81-86.

Bibliografía ácido lipoico

 

  • Bilska A, Włodek L. Lipoic acid - the drug of the future? Pharmacol Rep. 2005;57(5):570-577.
  • Biswas, S. K. and I. Rahman (2009). "Environmental toxicity, redox signaling and lung inflammation: the role of glutathione." Mol Aspects Med 30(1-2): 60-76.
  • Carbonelli M G, Di Renzo L, Bigioni M, Di Daniele N, De Lorenzo A, Fusco M A. (2010). Alpha-lipoic acid supplementation: a tool for obesity therapy? Curr Pharm Des. 2010; 16(7):840-6.
  • Carlson DA, Smith AR, Fischer SJ, Young KL, Packer L. The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects. Altern Med Rev. 2007;12(4):343-351.
  • Cervigón I, Torres LM, Palomo A. Síndrome de la boca ardiente y ácido alfa lipoico Actas Dermosifiliogr. 2009;100:151-162.
  • Ciftci H, Bakal U. The effect of lipoic acid on macro and trace metal levels in living tissues exposed to oxidative stress. Anticancer Agents Med Chem. 2009;9(5):560-568.
  • Cho YS, Lee J, Lee TH, Lee EY, Lee KU, Park JY, Moon HB. a-Lipoic acid inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Allergy Clin Immunol 2004;114:429-435.
  • Doggrell SA. Alpha-lipoic acid, an anti-obesity agent? Expert Opin Investig Drugs. 2004;13(12):1641-1643.
  • Foster TS. Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ. 2007;33(1):111-117.
  • Ghibu S, Richard C, Delemasure S, Vergely C, Mogosan C, Muresan A. An endogenous dithiol with antioxidant properties: alpha-lipoic acid, potential uses in cardiovascular diseases. Ann Cardiol Angeiol (Paris). 2008;57(3):161-165.
  • González-Pérez O, Moy-López NA, Guzmán-Muñiz J. Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine. Rev Invest Clin. 2008;60(1):58-67
  • Hatzitolios A, Iliadis F, Katsiki N, Baltatzi M. Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review. Ann Cardiol Angeiol (Paris). 2008;57(3):161-165.
  • Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999;27(3-4):309-314.
  • Jacob S, Rett K, Henriksen EJ, Häring HU. Thioctic acid--effects on insulin sensitivity and glucose-metabolism. Biofactors 1999;10(2-3):169-174.
  • Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid, Hormones 2006, 5(4):251-258.
  • Kendler BS.  Supplemental conditionally essential nutrients in cardiovascular disease therapy. J. Cardiovasc Nurs. 2006 Jan-Feb;21(1):9-16.
  • Lee KS, Kim SR, Park SJ, Min KH, Lee KY, Jin SM, Yoo WH, Lee YC. Antioxidant down-regulates interleukin-18 expression in asthma. Mol Pharmacol. 2006;70(4):1184-1193.
  • Maczurek A, Hager K, Kenklies M, Sharman M, Martins R, Engel J, Carlson DA, Münch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease. Adv Drug Deliv Rev. 2008;60(13-14):1463-1470.
  • Meister, A. (1994). "Glutathione-ascorbic acid antioxidant system in animals." J Biol Chem 269(13): 9397-9400.
  • McMackin CJ, Widlansky ME, Hamburg NM, Huang AL, Weller S, Holbrook M, Gokce N, Hagen TM, Keaney JF, Vita JA. Effect of Combined Treatment With -Lipoic Acid and Acetyl-L-Carnitine on Vascular Function and Blood Pressure in Patients With Coronary Artery Disease. J. Clin. Hypertens. 2007;9(4):249-255.
  • Mehta AK, Arora N, Gaur SN, Singh BP. Choline supplementation reduces oxidative stress in mouse model of allergic airway disease. Eur J Clin Invest. 2009;39(10):934-941.
  • Novotny L, Rauko P, Cojocel C. Alpha-Lipoic acid: the potential for use in cancer therapy. Neoplasma 2008;55(2):81-86.
  • Nualart, F. J., C. I. Rivas, et al. (2003). "Recycling of vitamin C by a bystander effect." J Biol Chem 278(12): 10128-10133.
  • O’Neill HC, Rancourt RC, White CW. Lipoic acid suppression of neutrophil respiratory burst: effect of NADPH. Antioxid Redox Signal. 2008;10(2):277-285.
  • Packer L, Kraemer K, Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001;17(10):888-895.
  • Padmalayam I, Hasham S, Saxena U, Pillarisetti S. Lipoic acid synthase (LASY): a novel role in inflammation, mitochondrial function, and insulin resistance. Diabetes. 2009;58(3):600-608.
  • Panigrahi M, Sadguna Y, Shivakumar BR, Kolluri SV, Roy S, Packer L, Ravindranath V. Alpha-Lipoic acid protects against reperfusion injury following cerebral ischemia in rats. Brain Res. 1996;717(1-2):184-188.
  • Perricone, C., C. De Carolis, et al. (2009). "Glutathione: a key player in autoimmunity." Autoimmun Rev 8(8): 697-701.
  • Prieto-Hontoria PL, Pérez-Matute P, Fernández-Galilea M, Barber A, Martínez JA, Moreno-Aliaga MJ. Lipoic acid prevents body weight gain induced by a high fat diet in rats: effects on intestinal sugar transport. J Physiol Biochem 2009,65 (1): 43-50.
  • Rottner, M., J. M. Freyssinet, et al. (2009). "Mechanisms of the noxious inflammatory cycle in cystic fibrosis." Respir Res 10: 23.
  • Ruhe RC, McDonald RB. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J Am Coll Nutr. 2001;20(5 Suppl):363S-369S; discussion 381S-383S.
  • Salinthone, S., V. Yadav, et al. (2008). "Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS." Endocr Metab Immune Disord Drug Targets 8(2): 132-142.
  • Shay KP, Moreau RF, Smith EJ, Smith AR, Hagen TM. Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential. Biochim Biophys Acta. 2009;1790(10):1149-1160.
  • Selvaraj N, Bobby Z, Sathiyapriya V. Effect of lipid peroxides and antioxidants on glycation of hemoglobin: an in vitro study on human erythrocytes. Clin Chim Acta. 2006;366(1-2):190-195.
  • Shen W, Liu K, Tian C, Yang L, Li X, Ren J, Packer L, Cotman CW, Liu J. R-alpha-lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine. 3T3-L1 adipocytes, Diabetologia 2008, 51(1):165-174.
  • Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev. 2008;66(11):646-657.
  • Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV. Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study, Circulation 2005; 111(3) 343-348.
  • Tripathi P, Singh BP, Arora N. Mutated glutathione-S-transferase reduced airway inflammation by limiting oxidative stress and Th2 response. Free Radic Biol Med. 2008 15;45(10):1413-1419.
  • Udupa AS, Nahar PS, Shah SH. Study of comparative effects of antioxidants on insulin sensivity in tipe 2 diabetes mellitus. J CLin Diagn Res. 2012 Nov;6(9):1469-73.
  • Vasdev S, Gill V, Singal P. Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications. Cell Biochem Biophys. 2007;49(1):48-63.
  • Wray DW, Uberoi A, Lawrenson L, Bailey DM, Richardson RS. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome. Clin Sci (Lond). 2009 Mar;116(5):433-441.
  • Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation. 2008;117(3):421-428.
  • Zhang WJ, Wei H, Hagen T, Frei B. Alpha-lipoic acid attenuates LPS-induced inflammatory responses by activating the phosphoinositide 3-kinase/Akt signaling pathway. Proc Natl Acad Sci U S A. 2007;104(10):4077-4082.
  • Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care. 1997;20(3):369-373.